Not logged in Share Save
Share Save
Share Save
Share Save
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWERCSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 Hughes, Brett G. M.; Guminski, Alexander; Bowyer, Samantha; Migden, Michael R.; Schmults, Chrysalyne D.; Khushalani, Nikhil I.; Chang, Anne Lynn S.; Grob, Jean-Jacques; Lewis, Karl D.; Ansstas, George; Day, Fiona; Ladwa, Rahul; Stein, Brian N.; Couselo, Eva Munoz; Meier, Friedegund; Hauschild, Axel; Schadendorf, Dirk; Basset-Seguin, Nicole; Modi, Badri; Dalac-Rat, Sophie; Dunn, Lara A.; Flatz, Lukas; Mortier, Laurent; Guegan, Sarah; Heinzerling, Lucie M.; Mehnert, Janice M.; Trabelsi, Sabiha; Soria-Rivas, Ainara; Stratigos, Alexander J.; Ulrich, Claas; Wong, Deborah J.; Beylot-Barry, Marie; Bossi, Paolo; Sanchez, Cristina Buges; Chandra, Sunandana; Robert, Caroline; Russell, Jeffery S.; Silk, Ann W.; Booth, Jocelyn; Yoo, Suk-Young; Seebach, Frank; Lowy, Israel; Fury, Matthew G.; Rischin, Danny Share Save
Share Save
Culturally secure strategies for treating child chronic wet cough Lau, Gloria; Laird, Pam; Aitken, Robyn; Barwick, Melanie; Mccallum, Gabrielle; Morris, Peter; Norman, Richard; Toombs, Maree; Walker, Roz; Chang, Anne; Schultz, Andre Share Save
Share Save
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors Lewisy, K. D.; Peris, K.; Sekulic, A.; Stratigos, A. J.; Dunn, L.; Eroglu, Z.; Chang, A. L. S.; Migden, M. R.; Yoo, S. -Y.; Mohan, K.; Coates, E.; Okoye, E.; Bowlerz, T.; Baurain, J. -F; Bechter, O.; Hauschild, A.; Butler, M. O.; Hernandez-Ayax, L.; Licitra, L.; Neves, R. I.; Ruiz, E. S.; Seebach, F.; Lowy, I.; Goncalves, P.; Fury, M. G. Share Save
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up Stratigos, Alexander J.; Sekulic, Aleksandar; Peris, Ketty; Bechter, Oliver; Prey, Sorilla; Lewis, Karl D.; Basset-Seguin, Nicole; Chang, Anne Lynn S.; Dalle, Stephane; Orland, Almudena Fernandez; Licitra, Lisa; Robert, Caroline; Ulrich, Claas; Hauschild, Axel; Migden, Michael R.; Dummer, Reinhard; Yoo, Suk-Young; Okoye, Emmanuel; Bassukas, Ioannis; Loquai, Carmen; De Giorgi, Vincenzo; Eroglu, Zeynep; Gutzmer, Ralf; Ulrich, Jens; Puig, Susana; Inocencio, Timothy J.; Chen, Chieh-, I; Lafontaine, Patrick R.; Seebach, Frank; Lowy, Israel; Fury, Matthew G. Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3 Migden, M. R.; Schmults, C.; Khushanlani, N.; Guminski, A.; Chang, A. L.; Lewis, K.; Ansstas, G.; Bowyer, S. E.; Hughes, B. G. M.; Schadendorf, D.; Modi, B.; Dunn, L.; Flatz, L.; Hauschild, A.; Yoo, S-Y.; Booth, J.; Seebach, F.; Lowy, I.; Fury, M. G.; Rischin, D. Share Save
Share Save
Share Save
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis Rischin, Danny; Khushalani, Nikhil, I; Schmults, Chrysalyne D.; Guminski, Alexander; Chang, Anne Lynn S.; Lewis, Karl D.; Lim, Annette M.; Hernandez-Aya, Leonel; Hughes, Brett G. M.; Schadendorf, Dirk; Hauschild, Axel; Thai, Alesha A.; Stankevich, Elizabeth; Booth, Jocelyn; Yoo, Suk-Young; Li, Siyu; Chen, Zhen; Okoye, Emmanuel; Chen, Chieh-, I; Mastey, Vera; Sasane, Medha; Lowy, Israel; Fury, Matthew G.; Migden, Michael R. Share Save
Share Save